Literature DB >> 24280446

Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.

Esmée Verwijk1, Hannie C Comijs2, Rob M Kok1, Harm-Pieter Spaans1, Caroline E M Tielkes3, Erik J A Scherder4, Max L Stek2.   

Abstract

BACKGROUND: It is generally assumed that the elderly patients are more vulnerable to cognitive side effects after electroconvulsive therapy (ECT) than younger depressed patients. The current study aims to evaluate the nature and extent of changes across multiple domains of neurocognitive functioning in a group of elderly depressed patients after ECT.
METHODS: In this prospective naturalistic study, we included 42 depressed patients aged ≥55 years. Global cognitive function, memory, and executive function were assessed before ECT treatment and within one week (short-term post-ECT) and six months after ECT (long-term post-ECT). Associations between cognitive functioning and electrode placement, total number of treatment sessions, age, and the severity of depression at the time of cognitive measurement were studied.
RESULTS: Our data offered no evidence of decline for any of the neurocognitive tests after ECT, given its power to detect the difference. Post-ECT improvement of neurocognitive functioning was statistically significant for the Mini-Mental State Examination, Visual Association Test, 10 Words Verbal Learning Test, and Expanded Mental Control Test. Effect sizes were medium to large. After six months, compared with post-ECT performance, statistically significant improvement was found only for the Trail Making Test-A and the Letter Fluency Test with small to medium effect sizes.
CONCLUSIONS: In our severely depressed elderly patients, neurocognitive performance improved or did not change after ECT. Patients with poor cognitive function were not able to participate in neuropsychological assessment before ECT started. Consequently these results may not apply to patients with more severe cognitive impairment prior to the start of ECT.

Entities:  

Mesh:

Year:  2013        PMID: 24280446     DOI: 10.1017/S1041610213001932

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  11 in total

Review 1.  Neuromodulation therapies for geriatric depression.

Authors:  Verònica Gálvez; Kerrie-Anne Ho; Angelo Alonzo; Donel Martin; Duncan George; Colleen K Loo
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

Review 2.  Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy.

Authors:  Shawn M McClintock; Jimmy Choi; Zhi-De Deng; Lawrence G Appelbaum; Andrew D Krystal; Sarah H Lisanby
Journal:  J ECT       Date:  2014-06       Impact factor: 3.635

3.  The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression.

Authors:  Sanne J H van Rooij; Patricio Riva-Posse; William M McDonald
Journal:  Curr Treat Options Psychiatry       Date:  2020-06-03

4.  Predicting Retrograde Autobiographical Memory Changes Following Electroconvulsive Therapy: Relationships between Individual, Treatment, and Early Clinical Factors.

Authors:  Donel M Martin; Verònica Gálvez; Colleen K Loo
Journal:  Int J Neuropsychopharmacol       Date:  2015-06-19       Impact factor: 5.176

Review 5.  Brain Stimulation in Alzheimer's Disease.

Authors:  Chun-Hung Chang; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Front Psychiatry       Date:  2018-05-22       Impact factor: 4.157

6.  Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study.

Authors:  Lei Zou; Su Min; Qibin Chen; Xiao Li; Li Ren
Journal:  Brain Behav       Date:  2020-12-11       Impact factor: 2.708

7.  Study of effect of nimodipine and acetaminophen on postictal symptoms in depressed patients after electroconvulsive therapy (SYNAPSE).

Authors:  Joey P A J Verdijk; Julia C M Pottkämper; Esmée Verwijk; Guido A van Wingen; Michel J A M van Putten; Jeannette Hofmeijer; Jeroen A van Waarde
Journal:  Trials       Date:  2022-04-18       Impact factor: 2.728

8.  Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.

Authors:  Sarah H Lisanby; Shawn M McClintock; William V McCall; Rebecca G Knapp; C Munro Cullum; Martina Mueller; Zhi-De Deng; Abeba A Teklehaimanot; Matthew V Rudorfer; Elisabeth Bernhardt; George Alexopoulos; Samuel H Bailine; Mimi C Briggs; Emma T Geduldig; Robert M Greenberg; Mustafa M Husain; Styliani Kaliora; Vassilios Latoussakis; Lauren S Liebman; Georgios Petrides; Joan Prudic; Peter B Rosenquist; Shirlene Sampson; Kristen G Tobias; Richard D Weiner; Robert C Young; Charles H Kellner
Journal:  Am J Geriatr Psychiatry       Date:  2021-05-17       Impact factor: 4.105

9.  Cognitive function after electroconvulsive therapy for depression: relationship to clinical response.

Authors:  Ian M Anderson; R Hamish McAllister-Williams; Darragh Downey; Rebecca Elliott; Colleen Loo
Journal:  Psychol Med       Date:  2020-02-27       Impact factor: 7.723

10.  Cognitive Considerations in Major Depression: Evaluating the Effects of Pharmacotherapy and ECT on Mood and Executive Control Deficits.

Authors:  Alfredo Spagna; Jason Wang; Isabella Elaine Rosario; Li Zhang; Meidan Zu; Kai Wang; Yanghua Tian
Journal:  Brain Sci       Date:  2022-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.